Clinical Trial

FRED Retrospective Study of Intracranial Aneurysms Treatment

Study acronym: FRED
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market environment
Trial Details
NCT Number NCT06982781
Lead Sponsor Microvention-Terumo, Inc.
Conditions Intracranial Aneurysm
Enrollment 2,000 participants
Start Date 2025-05
Primary Completion 2027-05-06 (estimated)
Study Completion 2027-05-06 (estimated)
Updated on ClinicalTrials.gov 2025-05-21